SAP SE vs Smith & Nephew plc — how do they compare? SAP SE trades at $207.97 (market cap $245.39B), while Smith & Nephew plc trades at $27.96 (market cap $11.62B). The key difference: SAP SE is far larger — about 21.1× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.86%). Which is the better fit depends on your goals.
| SAP | SNN | |
|---|---|---|
Market Cap | $245.39B | $11.62B |
Sector | Technology | Health |
52-Week High | $280.46 | $38.53 |
52-Week Low | $146.38 | $27.80 |
Enterprise Value | $244.09B | $14.66B |
Dividend Yield | 1.4% | 2.86% |
Signals from Pluang's Aura AI — not financial advice
SAP trades at $211.55, down 1.66% today, near the consensus price target of $209.67. The stock shows mixed signals with a neutral technical outlook, strong profitability margins above 20%, and recent earnings beating expectations in two of the last three quarters. Cloud revenue growth and AI initiatives are key drivers, supported by a €10 billion buyback program through 2027.
Outlook is cautiously optimistic with upside to the high target of $242, but risks include slower AI monetization and competitive pressures. Investors should weigh robust fundamentals against near-term execution challenges in a volatile software sector.
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
Trailing returns across standard periods
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →